Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 9,486 shares at $14.23 ($135K) on 2025-12-05, disclosed to the SEC on 2025-12-05.
Seasonal sale ($135k) by President and CEO — this insider has traded ENTA in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.23 | 4,743 | $67K | 50.0% |
| 2 | $14.23 | 4,743 | $67K | 50.0% |
| Total | $14.23 avg | 9,486 | $135K | 100% |
| Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |
| ENTA | SELL | 2022-12-16 | $2.3M | — | Filing → |